Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research.

Baroke E, Gauldie J, Kolb M.

Expert Rev Respir Med. 2013 Oct;7(5):465-78. doi: 10.1586/17476348.2013.838015. Review.

PMID:
24138691
2.

PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery.

Maher TM.

Eur Respir Rev. 2013 Jun 1;22(128):148-52. doi: 10.1183/09059180.00000913. Review.

3.

Emerging therapeutic interventions for idiopathic pulmonary fibrosis.

Chakraborty S, Chopra P, Ambi SV, Dastidar SG, Ray A.

Expert Opin Investig Drugs. 2014 Jul;23(7):893-910. doi: 10.1517/13543784.2014.913569. Epub 2014 Apr 28. Review.

PMID:
24766571
4.

Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future.

Antoniou KM, Margaritopoulos GA, Siafakas NM.

Eur Respir Rev. 2013 Sep 1;22(129):281-91. doi: 10.1183/09059180.00002113. Review.

5.

Interstitial lung disease.

Cottin V.

Eur Respir Rev. 2013 Mar 1;22(127):26-32. doi: 10.1183/09059180.00006812. Review.

6.

Current and future treatment options in idiopathic pulmonary fibrosis.

Hauber HP, Blaukovitsch M.

Inflamm Allergy Drug Targets. 2010 Jul;9(3):158-72. Review.

PMID:
20518722
7.

Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.

Azuma A.

Expert Rev Respir Med. 2010 Jun;4(3):301-10. doi: 10.1586/ers.10.32. Review.

PMID:
20524912
8.

Idiopathic pulmonary fibrosis.

Adkins JM, Collard HR.

Semin Respir Crit Care Med. 2012 Oct;33(5):433-9. Epub 2012 Sep 21.

PMID:
23001798
9.
10.

Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach?

Mahendran S, Sethi T.

QJM. 2012 Oct;105(10):929-34. Epub 2012 May 29. Review.

PMID:
22647761
11.

Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.

Pitsiou G, Papakosta D, Bouros D.

Respiration. 2011;82(3):294-304. doi: 10.1159/000327918. Epub 2011 Jun 15. Review.

12.

Common pathways in idiopathic pulmonary fibrosis and cancer.

Vancheri C.

Eur Respir Rev. 2013 Sep 1;22(129):265-72. doi: 10.1183/09059180.00003613. Review.

13.

Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors.

Farkas L, Gauldie J, Voelkel NF, Kolb M.

Am J Respir Cell Mol Biol. 2011 Jul;45(1):1-15. doi: 10.1165/rcmb.2010-0365TR. Epub 2010 Nov 5. Review.

PMID:
21057104
14.

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial.

Taniguchi H, Kondoh Y, Ebina M, Azuma A, Ogura T, Taguchi Y, Suga M, Takahashi H, Nakata K, Sato A, Sugiyama Y, Kudoh S, Nukiwa T; Pirfenidone Clinical Study Group in Japan.

Respir Res. 2011 Jul 15;12:93. doi: 10.1186/1465-9921-12-93.

15.

Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Craig VJ, Zhang L, Hagood JS, Owen CA.

Am J Respir Cell Mol Biol. 2015 Nov;53(5):585-600. doi: 10.1165/rcmb.2015-0020TR. Review.

16.

Serum biomarkers in idiopathic pulmonary fibrosis.

van den Blink B, Wijsenbeek MS, Hoogsteden HC.

Pulm Pharmacol Ther. 2010 Dec;23(6):515-20. doi: 10.1016/j.pupt.2010.08.001. Epub 2010 Aug 12. Review.

PMID:
20708704
17.

[Idiopathic pulmonary fibrosis: new insights].

Kraan JW, van den Blink B, van den Toorn LM, Bresser P, van Beek FT, Grutters JC, Wijsenbeek MS.

Ned Tijdschr Geneeskd. 2015;159:A8148. Review. Dutch.

PMID:
25654681
18.

Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients?

Costabel U.

Eur Respir Rev. 2011 Sep 1;20(121):201-7. doi: 10.1183/09059180.00002011. Review.

19.

Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis.

Yan Z, Kui Z, Ping Z.

Autoimmun Rev. 2014 Oct;13(10):1020-5. doi: 10.1016/j.autrev.2014.08.028. Epub 2014 Aug 23. Review.

PMID:
25182202
20.

Exploitation of Novel Molecular Targets to Treat Idiopathic Pulmonary Fibrosis: A Drug Discovery Perspective.

Vaidya B, Patel R, Muth A, Gupta V.

Curr Med Chem. 2017;24(22):2439-2458. doi: 10.2174/0929867324666170526123607. Review.

PMID:
28552057

Supplemental Content

Support Center